Literature DB >> 3383167

Transformation of polycythemia vera to acute nonlymphocytic leukemia accompanied by t(1;3)(p36;q21) karyotype.

V Najfeld1, T Coyle, P D Berk.   

Abstract

The case of a patient with a history of polycythemia vera and 46,XX karyotype who transformed into acute nonlymphocytic leukemia with 46,XX,t(1;3)(p36;q21) rearrangement is reported. Significant percentages of the circulating blasts in the peripheral blood were positive on immunocytochemical stains for megakaryocyte markers, anti-Factor VIII, and antiglycoprotein IIb/IIIa. On the basis of our studies and published reports, trilineage hematopoietic abnormalities and a poor response to therapy may represent typical features of patients with t(1;3).

Entities:  

Mesh:

Year:  1988        PMID: 3383167     DOI: 10.1016/0165-4608(88)90029-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.

Authors:  Xiaoli Wang; Sonam Prakash; Min Lu; Joseph Tripodi; Fei Ye; Vesna Najfeld; Yan Li; Myron Schwartz; Rona Weinberg; Paul Roda; Attilio Orazi; Ronald Hoffman
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

2.  A Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis.

Authors:  Ceyla Konca Degertekin; Zübeyde Nur Ozkurt; Nalan Akyürek; Münci Yağcı
Journal:  Indian J Hematol Blood Transfus       Date:  2012-12-07       Impact factor: 0.900

3.  C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.

Authors:  Xiaoli Wang; Sool Yeon Cho; Cing Siang Hu; Daniel Chen; John Roboz; Ronald Hoffman
Journal:  Exp Hematol       Date:  2014-11-08       Impact factor: 3.084

4.  JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis.

Authors:  Xiaoli Wang; Fei Ye; Joseph Tripodi; Cing Siang Hu; Jiajing Qiu; Vesna Najfeld; Jesse Novak; Yan Li; Raajit Rampal; Ronald Hoffman
Journal:  Blood       Date:  2014-09-05       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.